Conditional knockout mice are commonly used to study the function of specific genes in hematopoiesis. Different promoters that drive Cre expression have been utilized, with the interferon-inducible Mx1-Cre still being the most commonly used ''deleter strain'' in experimental hematology. However, different pitfalls associated with this system could lead to misinterpretation in functional studies. We present here two of these issues related to the use of Mx1-Cre: first, a high spontaneous recombination rate when applying commonly used techniques in experimental hematology, and second, undesired short-term consequences of the use of polyinosinic:polycytidylic acid, including changes in cellular phenotypes that, however, resolve within days. Our studies emphasize therefore that proper controls are crucial when modeling gene deletion using the Mx1-Cre transgene.
INTRODUCTION
Conditional knockout (cKO) mice based on Cre-mediated excision (Jiang and Gridley, 1997) are frequently used when studying normal and malignant hematopoiesis. Most cKO models are generated by flanking a gene segment of interest with loxP sites, which allows for its removal in a cell-or tissue-specific manner by Cre recombinase. The Mx1-Cre model (Kuhn et al., 1995) represents the most commonly used ''deleter strain'' in experimental hematology. In this strain, the Mx dynamin-like GTPase 1 (Mx1) promoter is activated in an interferon-dependent manner following injection of polyinosinic:polycytidylic acid (pIpC), which results in downstream expression of Cre recombinase. Despite the wide use of the Mx1-Cre strain, caution has to be entertained due to caveats that have not been well described. These include spontaneous recombination and undesired side effects caused by the pIpC itself.
In experimental hematology, bone marrow (BM) transplantation represents a key approach in the investigation of the role of specific genes. Most often, this is performed with cells obtained from cKO mice. We show here that the transplantation assay and expression of an activated receptor tyrosine kinase ITD ) can trigger spontaneous
Mx1-Cre-driven deletion of floxed genes, which substantially exceeded the 2%-3% originally reported (Kemp et al., 2004; Kuhn et al., 1995; Mupo et al., 2013) . In addition, we observed transient changes in phenotype and frequency of hematopoietic stem and progenitor cells (HSPCs) after pIpC injection, which could lead to incorrect identification of subsets of cells in short-term studies.
Finally, we propose a potential alternative strategy for gene deletion using an ex vivo Tat-Cre-recombination approach. Awareness of these shortcomings has high relevance for hematopoietic research because it can aid in experimental design and avoid potential errors in the interpretation of results.
RESULTS

Transplantation Induces Uncontrolled Recombination in Hematopoietic Cells from
Mx1-Cre Mice To study the influence of HIF-1a in the initiation of leukemia, we retrovirally introduced different oncogenes into Mx1-Cre; Hif-1a flox/flox cKIT + cells and transplanted them into wild-type (WT) recipients (Velasco-Hernandez et al., 2014) . Surprisingly, we observed an unexpectedly high deletion frequency of the floxed gene prior to pIpC injection, ranging between 30% and 50% ( Figure 1A ). To identify experimental procedures that contribute to the spontaneous Mx1-Cre activation, we crossed Rosa26-Lox-Stop-Lox-YFP (YFP LSL ) reporter mice (Srinivas et al., 2001 ) with the Mx1-Cre mice. HSPCs from these mice were next subjected to a routine protocol for transduction/transplantation experiments, using retroviral vectors encoding fluorescence proteins ( Figures 1B-1G ). Isolated unmanipulated cells from donor mice displayed a spontaneous recombination close to 20% ( Figures 1C, 1D , 1E, 1H, and S1). Analyses after transplantation indicated that Hif-1a flox/flox HSPCs before (week 3 post-transplantation) and after pIpC injection (pIpC injection at week 4 and analysis at week 7). Plots show two independent experiments, using either AML1-ETO9a or MLL-AF9 expressing donor cells. (B) Experimental setup for analysis of spontaneous deletion in a commonly used transduction/transplantation protocol. Donor cells were collected from five separate animals. (C) Variation in frequency of recombined cells (YFP+) along the different steps of the protocol described in (B). Percentage of recombined cells is calculated within the donor-derived population after the transplantation step. *p < 0.05.
(legend continued on next page) the percentage of YFP+ (recombined) cells in the donorderived compartment had increased significantly at week 10 ( Figures 1C and S1 ). To address if this was due to the transduction or transplantation procedures, we performed the same protocol with or without transduction ( Figures  1G and S1 ). Analysis of BM and spleen cells 15 days after transplantation indicated that the levels of recombination were similar in both groups. However, the frequency of recombined cells increased by 50% as a consequence of the transplantation, despite the lack of an evident positive selection pressure in favor of the recombined cells. Investigations into the effect of retroviral transduction in a more primitive and homogeneous population (Lin À SCA1 + cKIT + , LSK cells) also failed to reveal increments in recombination 48 hr after transduction ( Figures 1D and S2 ). Furthermore, no significant increase in recombination was observed when culturing unfractionated BM cells, including more mature populations that could include interferon-producing cells ( Figure 1E ). Finally, to conclusively exclude a potential positive selection of already recombined cells that could increase in vivo after transplantation, we sorted cKIT+ YFPÀ cells from YFP LSL ; Mx1-Cre mice and transplanted them into WT recipients without pIpC injection ( Figure 1H ). This revealed 10%-20% of YFP+ donor cells 15 days after transplantation in donor BM and spleen cells of transplanted mice. These results demonstrate that the major cause of the unexpectedly high levels of spontaneous gene deletion is caused by the transplantation procedure per se.
Constitutively Active Flt-3 Induces Spontaneous Recombination in Mx1-Cre Mice We recently crossed Hif-1a cKO mice with Flt-3 ITD knockin mice. We observed that a large fraction of hematopoietic cells in these mice showed a spontaneous deletion prior to pIpC injection ((Velasco-Hernandez et al., 2015) and Figure 2A) , consistent with previous publications (Mead et al., 2013; Mupo et al., 2013) . To test if this was present also early in development, we analyzed deletion in fetal liver (FL) cells. FL hematopoietic cells showed either no deletion or only a minor portion of deleted cells in a few colonies (Figures 2A and S3) , indicating that spontaneous Mx1-Cre-mediated excision is a cumulative effect during the lifespan of these animals. Since it has been reported that floxed alleles have different sensitivities to Cre-induced recombination (Liu et al., 2013) , we investigated spontaneous recombination in a different (Phd2 flox/flox ; Mx1-Cre;
Flt-3 ITD/+ ) model. Using this, colonies derived from BM cells were analyzed and consistently presented a high rate of recombination in the absence of pIpC injection ( Figures  2B and S3 ). Because FLT-3 signaling is critical for dendritic cell (DC) differentiation and proliferation (Gilliet et al., 2002; Karsunky et al., 2003; Maraskovsky et al., 1996; O'Keeffe et al., 2002) , and plasmacytoid DCs (pDCs) are prominent producers of interferon (Colonna et al., 2004) , we analyzed BM and spleen in Flt-3 ITD mice for pDCs and classical DCs (cDCs) (Figures 2C, 2D, and S3) . In both organs, we observed increments in pDCs and cDCs when comparing Flt-3 ITD/+ with WT mice. These data imply that spontaneous recombination can be induced by FLT-3 ITD expression, probably in an interferon-dependent manner, illustrating that this phenomenon is not unique to the transplantation system.
The Immunophenotype of HSPCs Is Transiently Perturbed Following pIpC Administration
Interferon signaling has previously been shown to enhance proliferation of HSPCs in vivo (Baldridge et al., 2010; Essers et al., 2009) . To evaluate this, we took advantage of an in vivo approach in which a histone 2B-mCherry fusion protein can be conditionally expressed in a doxycyclineinducible manner (Sawen et al., 2016) . Col1a1-tetO-H2B-mCherry mice were administered doxycycline to label the pool of HSPCs, followed by assessments of mCherry intensities in phenotypically defined subsets at different time points (days 1, 3, 8, and 24) after pIpC or PBS (control) injections. While proliferation of hematopoietic stem cells (HSCs, Lin
was not appreciably altered at any time point after pIpC injections ( Figure 3A ), lower mCherry intensities LSL ; Mx1-Cre cKIT+ cells were isolated and directly transplanted or transduced with GFP virus before transplantation. Recombination levels were analyzed 15 days after transplantation (donor mice, n = 3; transplanted mice, n = 10). Recombination levels are normalized to initial YFP+ cells values from each independent donor. Transduction levels were between 10% and 50%. Pooled data from two independent experiments. *p < 0.05, **p < 0.01. Figure 3A) . However, this effect was not observed at later time points. While this potentially could reflect an elimination of more rapidly proliferating cells at later times, the frequencies of different HSPC subsets ( Figure S4 ) were dramatically altered early after pIpC injections, but largely normalized after 3 days (Figures 3B and 3C ). We noted transient elevations in the levels of SCA1 1 day after pIpC injections, leading to higher expression and frequency of SCA1 + cells (Figure 3D ). This declined to levels observed in untreated mice relatively rapidly. Therefore, pIpC doses typically used for Cre induction do not cause any pronounced effects on HSPC proliferation, but pIpC-mediated induction of SCA1 can complicate more refined phenotypic analyses of these cells by ''pushing'' SCA1 À/low progenitor cells into the pool of more primitive LSK cells. These data highlight an additional and unwanted transient effect of pIpC administration on hematopoiesis that can lead to erroneous conclusions on cell identities in short-term studies (before day 8).
An Alternative In Vitro Cre-Recombination Strategy Using Ex Vivo Tat-Cre Treatment Finally, to explore an alternative approach to the Mx1-Cre-mediated recombination, we subjected HSPCs from Rosa26-LoxP-Stop-LoxP-RFP(TdTomato) (TdTomato LSL )
mice to a brief in vitro exposure to recombinant TatCre. This revealed an efficient induction of RFP expression, with no spontaneous deletion in the absence of Tat-Cre ( Figures 4A and 4B) . We next applied this deletion strategy to investigate the impact of an activating KRAS G12D mutation on MLL-ENL-driven leukemia in vivo.
This KRAS G12D model has previously been shown to associate with a relatively high level of spontaneous activation when crossed to Mx1-Cre mice (Chan et al., 2004; Sabnis et al., 2009 ). After crossing doxycycline-inducible MLL-ENL mice (Ugale et al., 2014) to the KRAS LSLÀG12D strain, we sorted HSCs and subjected these to Tat-Cre or sham recombination, followed by transplantation. As expected (Ugale et al., 2014) ITD/+ and WT animals (n = 6). Plots show mean ± SEM. **p < 0.01, ***p < 0.001. See also Figure S3 .
develop leukemia, while all recipients with combined activation of KRAS G12D and MLL-ENL (+ Tat-Cre) developed myeloid leukemia within 10 weeks ( Figure 4C ). To test this strategy in a non-leukemic model in which recombined cells have no selective advantage, we isolated LSK cells from the YFP LSL model (lacking Mx1-Cre) and applied the same protocol ( Figures 4D and 4E) . We observed recombination rates of 2%-8%, also present in BM and spleen cells 15 days after transplantation. We did not observe any undesired recombination in sham-recombined cells. These results demonstrate the utility of an alternative recombination strategy that can circumvent some of the technical caveats associated with the Mx1-Cre system, although we have not rigorously shown that recombination occurs in stem cells with this system.
DISCUSSION
In experimental hematopoiesis, the requirement of specific genes for normal HSC function, initiation, and maintenance of leukemia, using either transplantation alone or the retroviral transduction/transplantation model, has been tested extensively using specific cKO mice (Kocabas et al., 2012; Takeishi et al., 2013; Wang et al., 2010; Zhang et al., 2004) . However, the requirement of a specific gene for leukemia initiation will be difficult to evaluate if the gene to be tested is deleted in an uncontrolled manner.
It is a general assumption that deletion of floxed genes using the Mx1-Cre system occurs by pIpC injections either in steady-state hematopoiesis or after engraftment into recipients. Yet, despite its widespread use, little information is available on baseline levels of recombination and the influence of transplantation itself on spontaneous gene deletion. When we investigated the role of HIF-1a in leukemia initiation by transducing HSPCs from Hif-1a cKO mice with leukemic oncogenes, we observed a 40% gene deletion frequency after transplantation, but prior to pIpC injections. This led us to further investigate this phenomenon because of its broader importance for hematopoiesis and leukemia research, in which these methods are commonly used.
In the literature, a spontaneous recombination rate of 2%-3% when using the Mx1-Cre deleter strain has been described (Kemp et al., 2004; Kuhn et al., 1995; Mupo et al., 2013) . Even a low recombination rate can lead to a high gene deletion frequency if the cells with the deleted gene have a growth advantage; for example, when investigating leukemia initiation. Based on our findings, Mx1-Cre mice not injected with pIpC should be included in all experiments using this model and deletion assessed before initiation of experiments. This is not unique to the transplantation scenario, as we observed that activation of Mx1-Cre can also be triggered by an oncogene (constitutive active Flt-3). Activation of this pathway, which leads to excessive generation and activation of interferon-producing DCs, is likely induced also by other activated receptor . See also Figure S4 .
tyrosine kinases, and might therefore be particularly problematic in combination with the Mx1-Cre system. The Mx1-Cre system can be potentially associated with additional problems. For instance, pIpC administration has been suggested to trigger HSC cycling, similar to interferon itself (Essers et al., 2009; Gidali et al., 1981; Sugiyama et al., 2006) . While we found less evidence for a dramatic effect of pIpC in inducing HSPC proliferation, we noted that pIpC induced rapid and transient changes (that resolved by day 8) in cellular phenotypes, which could affect the interpretation of experimental results.
Several alternatives to the Mx1-Cre model can be found in the literature (Joseph et al., 2013; Kemp et al., 2004; Lewandoski, 2001; Rossi et al., 2012) . In addition, we provide evidence for the use of Tat-Cre recombinase (Peitz et al., 2002) as an alternative method (De Santa et al., 2007; Gordon et al., 2012; Li et al., 2014) . Because Tat-Cre-mediated excision represents an exogenous expression system, cells are not susceptible to undesired recombination. However, this method also has limitations since it relies on an ex vivo step for the treatment with Tat-Cre, and is therefore not compatible with steady-state studies or for the study of genes necessary for homing. In addition, we have observed a significant variation in the recombination rate depending on the floxed gene, as described previously for Cre strains in general (Liu et al., 2013) . Although the data we report herein displayed a rather low recombination rate, deletion efficiencies can be substantially increased in a cell-type-dependent and procedure-specific manner (data not shown). However, it is perhaps unlikely that the procedure will be able to reach 100% efficiencies. The titratable recombination rates can, however, also be beneficial, for instance in leukemogenesis studies, in which only a small percentage of recombined cells is desired.
In summary, we present evidence from multiple experimental conditions and procedures that can contribute to the induction of high spontaneous recombination in Mx1-Cre-based cKO mice. Being up to 20-fold higher than the ones reported in the literature for steady-state conditions, our studies highlight the importance of proper controls when applying this system to study gene function in the hematopoietic system.
EXPERIMENTAL PROCEDURES
Mice
The following mouse strains were used: Flt-3 ITD (Lee et al., 2007) (kindly provided by G. Gilliland), Mx1-Cre (Kuhn et al., 1995) , Hif-1a flox/flox (Ryan et al., 2000) , Phd2 flox/flox (kindly provided by P. Carmeliet), YFP LSL (Srinivas et al., 2001 ) (JAX 006148), Col1a1-tetO-H2B-mCherry (Egli et al., 2007) (JAX 014602), TdTomato LSL (Madisen et al., 2010 ) (JAX 007905), Col1a1-tetO-MLL/ENL (Ugale et al., 2014) , and KRAS LSL-G12D (Jackson et al., 2001 ) (JAX 008179).
To activate Mx1-Cre in vivo, 400 mg of pIpC (Sigma-Aldrich) was either injected three times every second day or once (analyzed samples at days 1 and 3). Mice were maintained at the animal facilities of the Biomedical Center at Lund University. All experiments were performed with consent from a local ethics committee.
Statistical Analysis
Data were analyzed using Microsoft Excel (Microsoft) and Prism 6 (GraphPad Software). Data are expressed as means ± SEM or SD. ''n'' always stands for individual mice. Differences between groups were assessed by two-tailed Student's t test. Survival rates were plotted using the Kaplan-Meier method (significance values were calculated by Mantel-Cox log rank test). *p < 0.05, **p < 0.01, ***p < 0.001. 
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